1 Market Overview
1.1 Vaccine Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Monovalent
1.2.2 Multivalent
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Influenza
1.3.2 Meningococcal
1.3.3 Pneumococcal
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Business Overview
2.1.2 Vaccine Conjugate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 GlaxoSmithKline plc.
2.2.1 Business Overview
2.2.2 Vaccine Conjugate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 SutroVax Inc.
2.3.1 Business Overview
2.3.2 Vaccine Conjugate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 SutroVax Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Fablife.
2.4.1 Business Overview
2.4.2 Vaccine Conjugate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fablife. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Vaccine Conjugate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Sinovac Biotech Ltd.
2.6.1 Business Overview
2.6.2 Vaccine Conjugate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Sanofi Pasteur SA.
2.7.1 Business Overview
2.7.2 Vaccine Conjugate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Vaccine Conjugate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Vaccine Conjugate Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Vaccine Conjugate Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Conjugate Manufacturer Market Share in 2019
3.3.2 Top 6 Vaccine Conjugate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Vaccine Conjugate Market Analysis by Regions
4.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Conjugate Sales and Market Share by Regions (2015-2019)
4.1.2 Global Vaccine Conjugate Revenue and Market Share by Regions (2015-2019)
4.2 North America Vaccine Conjugate Sales and Growth Rate (2015-2019)
4.3 Europe Vaccine Conjugate Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Vaccine Conjugate Sales and Growth Rate (2015-2019)
4.5 South America Vaccine Conjugate Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Vaccine Conjugate Sales and Growth Rate (2015-2019)
5 North America Vaccine Conjugate by Country
5.1 North America Vaccine Conjugate Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine Conjugate Sales and Market Share by Country (2015-2019)
5.1.2 North America Vaccine Conjugate Revenue and Market Share by Country (2015-2019)
5.2 United States Vaccine Conjugate Sales and Growth Rate (2015-2019)
5.3 Canada Vaccine Conjugate Sales and Growth Rate (2015-2019)
5.4 Mexico Vaccine Conjugate Sales and Growth Rate (2015-2019)
6 Europe Vaccine Conjugate by Country
6.1 Europe Vaccine Conjugate Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine Conjugate Sales and Market Share by Country (2015-2019)
6.1.2 Europe Vaccine Conjugate Revenue and Market Share by Country (2015-2019)
6.2 Germany Vaccine Conjugate Sales and Growth Rate (2015-2019)
6.3 UK Vaccine Conjugate Sales and Growth Rate (2015-2019)
6.4 France Vaccine Conjugate Sales and Growth Rate (2015-2019)
6.5 Russia Vaccine Conjugate Sales and Growth Rate (2015-2019)
6.6 Italy Vaccine Conjugate Sales and Growth Rate (2015-2019)
7 Asia-Pacific Vaccine Conjugate by Country
7.1 Asia-Pacific Vaccine Conjugate Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Vaccine Conjugate Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Vaccine Conjugate Revenue and Market Share by Country (2015-2019)
7.2 China Vaccine Conjugate Sales and Growth Rate (2015-2019)
7.3 Japan Vaccine Conjugate Sales and Growth Rate (2015-2019)
7.4 Korea Vaccine Conjugate Sales and Growth Rate (2015-2019)
7.5 India Vaccine Conjugate Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Vaccine Conjugate Sales and Growth Rate (2015-2019)
8 South America Vaccine Conjugate by Country
8.1 South America Vaccine Conjugate Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine Conjugate Sales and Market Share by Country (2015-2019)
8.1.2 South America Vaccine Conjugate Revenue and Market Share by Country (2015-2019)
8.2 Brazil Vaccine Conjugate Sales and Growth Rate (2015-2019)
8.3 Argentina Vaccine Conjugate Sales and Growth Rate (2015-2019)
8.4 Colombia Vaccine Conjugate Sales and Growth Rate (2015-2019)
9 Middle East and Africa Vaccine Conjugate by Countries
9.1 Middle East and Africa Vaccine Conjugate Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Vaccine Conjugate Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Vaccine Conjugate Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Vaccine Conjugate Sales and Growth Rate (2015-2019)
9.3 Turkey Vaccine Conjugate Sales and Growth Rate (2015-2019)
9.4 Egypt Vaccine Conjugate Sales and Growth Rate (2015-2019)
9.5 Nigeria Vaccine Conjugate Sales and Growth Rate (2015-2019)
9.6 South Africa Vaccine Conjugate Sales and Growth Rate (2015-2019)
10 Global Vaccine Conjugate Market Segment by Type
10.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Vaccine Conjugate Sales and Market Share by Type (2015-2019)
10.1.2 Global Vaccine Conjugate Revenue and Market Share by Type (2015-2019)
10.2 Monovalent Sales Growth and Price
10.2.1 Global Monovalent Sales Growth (2015-2019)
10.2.2 Global Monovalent Price (2015-2019)
10.3 Multivalent Sales Growth and Price
10.3.1 Global Multivalent Sales Growth (2015-2019)
10.3.2 Global Multivalent Price (2015-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2015-2019)
10.4.2 Global Others Price (2015-2019)
11 Global Vaccine Conjugate Market Segment by Application
11.1 Global Vaccine Conjugate Sales Market Share by Application (2015-2019)
11.2 Influenza Sales Growth (2015-2019)
11.3 Meningococcal Sales Growth (2015-2019)
11.4 Pneumococcal Sales Growth (2015-2019)
11.5 Others Sales Growth (2015-2019)
12 Vaccine Conjugate Market Forecast (2020-2025)
12.1 Global Vaccine Conjugate Sales, Revenue and Growth Rate (2020-2025)
12.2 Vaccine Conjugate Market Forecast by Regions (2020-2025)
12.2.1 North America Vaccine Conjugate Market Forecast (2020-2025)
12.2.2 Europe Vaccine Conjugate Market Forecast (2020-2025)
12.2.3 Asia-Pacific Vaccine Conjugate Market Forecast (2020-2025)
12.2.4 South America Vaccine Conjugate Market Forecast (2020-2025)
12.2.5 Middle East and Africa Vaccine Conjugate Market Forecast (2020-2025)
12.3 Vaccine Conjugate Market Forecast by Type (2020-2025)
12.3.1 Global Vaccine Conjugate Sales Forecast by Type (2020-2025)
12.3.2 Global Vaccine Conjugate Market Share Forecast by Type (2020-2025)
12.4 Vaccine Conjugate Market Forecast by Application (2020-2025)
12.4.1 Global Vaccine Conjugate Sales Forecast by Application (2020-2025)
12.4.2 Global Vaccine Conjugate Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source